BioSpace News Archive

Veracyte, Inc. (Nasdaq: VCYT) announced that data published today in the Journal of the National Cancer Institute demonstrate that the company’s Decipher Prostate Genomic Classifier may help identify African American men with early, localized prostate cancer who are most likely to harbor more aggressive disease.

Bicycle Health, the leading provider of virtual opioid addiction treatment, today announced an investment from Cobalt Ventures to further accelerate the expansion of its telehealth opioid use disorder (OUD) treatment.

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, and Asahi Intecc Co., a leading Japanese medical device manufacturer, announced that they will collaborate to introduce Penumbra’s Indigo™ Aspiration System into the Japanese market upon regulatory approval.

CubeWorks (www.cubeworks.io), a startup company accelerating the future of IoT through breakthrough smart sensing solutions, today introduces the next-generation visibility solution for cold chain logistics with the CubiSens™ XT1.

Dynarex Corporation, a leading durable medical equipment and disposable medical products company, is proud to honor Lainey Volk as the 2022 recipient of the Dynarex EMS First Responder Caring Award.

DyAnsys, Inc., has announced that Primary Relief, a percutaneous electrical neurostimulation device, has been approved to treat pain following a cardiac surgery.

The latest market analysis report published by Reports and Data, titled ‘Global Sialorrhea Market – Forecast to 2030,’ thoroughly examines the Sialorrhea industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Urothelial Carcinoma Market – Forecast to 2030,’ thoroughly examines the Urothelial Carcinoma industry to provide essential data & information for the targeted readers.

The bionics market is projected to reach USD 18.28 billion by 2025 from an estimated USD 7.11 billion in 2020, at a CAGR of 21.4% during the forecast period, according to a latest study by Emergen Research.

Slope, provider of the first eClinical Supply Chain Management (eCSCM) platform, announced that it has been identified as a Sample Vendor in the 2022 Gartner Hype Cycle for Life Science Clinical Development, 2022.